CNS Malignancies
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors (NCT02564198) | Eli Lilly and Company | 2015-12-11 |
| A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors (NCT00756340) | St. Jude Children's Research Hospital | 2008-07-01 |
Track CNS Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.